Search Results 301-310 of 19351 for prostate cancer
... prostate cancer by comparing the standard dose of radiation therapy (44 ... tumor models (i.e. organoids) that preserve the characteristics of the original tumor.
About this study. This is a single patient study of an investigational drug CPI-613 for treatment of metastatic prostate cancer. Participation eligibility.
Prostate biopsy plays a critical role in the diagnostic pathway for prostate cancer. For many years, the transrectal biopsy was the standard of care.
Clinical Trials · A Study to Compare Docetaxel/Prednisone to Docetaxel/Prednisone Combined with OGX-011 in Men with Prostate Cancer · More about research at Mayo ...
XmAb®20717 Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer · More about research ...
Safety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) ...
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy · Share · Facebook · Twitter.
A few such vaccines exist, and one is approved by the Food and Drug Administration for patients with prostate cancer. In many cases, these vaccines are used ...
... cancers, including prostate, kidney, bladder, and testicular cancers. ... prostate cancer; Research interests include biomarker development, molecular ...
2009 European Randomized Study of Screening for Prostate Cancer and Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial; 2013 American Urological ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Benefactor support fuels Mayo Clinic’s groundbreaking research. Make a gift today to help us save lives.